BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease

  Orbsen Therapeutics Limited, a global leader in stromal cell immunotherapies, announces encouraging headline interim results from the EU Horizon 2020-funded NEPHSTROM clinical trial for Diabetic Kidney Disease.

  January 26, 2023

   · 

  8 min read
• SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

  SN BioScience and Boryeong signed a domestic manufacturing technology transfer and co-development contract for the albumin nanoparticle anticancer drug developed by SN BioScience for the first time in Korea and the fourth time in the world.

  January 26, 2023

   · 

  3 min read
• Business

  Orexo Interim Report Q4 2022, incl. Full Year Report

  At 2 pm CET the same day as the announcement of the report Orexo invites analysts, investors and media to attend a presentation where Nikolaj Sørensen, CEO and Fredrik Järrsten, CFO, will present the report and host a Q&A.

  January 26, 2023

   · 

  3 min read
• Esaote presents the world premiere of its new MyLab™X90 ultrasound device

  Today Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated MRI and medical IT– presents the world premiere of MyLab™X90, its new premium ultrasound system.

  January 26, 2023

   · 

  3 min read